The compound showed high antiproliferative activity in a GIST-imatinib resistant cell line (GIST48) in short-term experiments (IC50 0.5 ± 0.05 μM, Table 4), did not affect telomerase activity in this cell line, and did not have a large effect on the KIT gene. This evidence concerns the gene KIT and gastrointestinal stromal tumor.